| 2026-06-29 | Dr. Antonio Peter BelperioNon-Executive Director | -589,29k | 0,00 | Other Derivative Disposition | - | - | - |
| 2026-06-29 | Mr. Peter Thomas McIntyreNon-Executive Director | -1,65M | 0,00 | Other Derivative Disposition | - | - | - |
| 2026-06-29 | Mr. Duncan C. ChessellMD, CEO & Director | -88,24k | 0,00 | Other Derivative Disposition | - | - | - |
| 2026-06-29 | Mr. Christopher Glen SutherlandIndependent Non-Executive Chairman | -815,80k | 0,00 | Other Derivative Disposition | - | - | - |
| 2026-05-19 | Mr. Duncan C. ChessellMD, CEO & Director | 1,66M | 0,00 | Derivative Exercise and Retained Stock | - | 3,37M | 96,26% |
| 2026-02-05 | Mr. Duncan C. ChessellMD, CEO & Director | -1,81M | 0,00 | Other Derivative Disposition | - | - | - |
| 2025-07-11 | Mr. Peter Thomas McIntyreNon-Executive Director | 2,94M | 32,73k | Kauf | 0,01 | 11,18M | 35,70% |
| 2025-07-22 | Dr. Antonio Peter BelperioNon-Executive Director | 1.000,00k | 11,13k | Kauf | 0,01 | 1,89M | 112,00% |
| 2025-07-22 | Mr. Gregory Campbell HallInsider | 588,24k | 6,55k | Kauf | 0,01 | 755,20k | 352,32% |
| 2025-07-22 | Mr. Duncan C. ChessellMD, CEO & Director | 176,47k | 1,96k | Kauf | 0,01 | 1,72M | 11,44% |
| 2025-07-22 | Mr. Peter Thomas McIntyreNon-Executive Director | 2,94M | 32,73k | Kauf | 0,01 | 11,18M | 35,70% |
| 2025-07-22 | Mr. Christopher Glen SutherlandIndependent Non-Executive Chairman | 1,18M | 13,09k | Kauf | 0,01 | 3,45M | 51,70% |